Patrick M. Sluss, PhD is an expert in the area of diagnostic chemistry. He is director of the Special Chemistry subspecialty within the Core Laboratory of the Mass General Hospital Pathology Service.

Patrick M. Sluss, PhD

Associate Clinical Chemist, non-clinical,
Massachusetts General Hospital

Associate Professor of Pathology,
Harvard Medical School

 

 

 

Biography

Dr. Sluss is an associate with the Laboratory and Molecular Medicine division of the Massachusetts General Hospital Pathology Service. 

Clinical Research Interests

Dr. Sluss pursues basic investigations of the biochemistry, physiology and pathophysiology of the activin-binding protein follistatin. Recent studies have focused upon identifying the specific epitopes directly involved with activin binding and delineating allosteric effects of activin binding in altering domain-specific antigenic epitopes in the holoprotein. In addition, his lab is involved in clinical studies directed toward developing methods and technological approaches for serum measurements of novel ovarian cancer markers using SELDI and other high resolution proteomic procedures. Finally, his lab conducts studies of current and new immunodiagnostic methods to evaluate their analytical performance and clinical utility. These studies encompass immunoassays for endocrine hormones, tumor markers, cardiac markers, and therapeutic drugs.

Publications

View all PubMed publications

  1.  A Call to Standardize Preanalytic Data Elements for Biospecimens, Part II. Robb JA, Bry L, Sluss PM, Wagar EA, Kennedy MF; for the College of American Pathologists Diagnostic Intelligence and Health Information Technology Biorepository Working Group 2. Arch Pathol Lab Med. 2015 Jan 16. [Epub ahead of print]
  2. The new instructions to authors for the reporting of steroid hormone measurements. Wierman ME, Auchus RJ, Haisenleder DJ, Hall JE, Handelsman D, Hankinson S, Rosner W, Singh RJ, Sluss PM, Stanczyk FZ. Horm Cancer. 2014 Dec;5(6):357. doi: 10.1007/s12672-014-0202-1. No abstract available.
  3. Editorial: the new instructions to authors for the reporting of steroid hormone measurements. Wierman ME, Auchus RJ, Haisenleder DJ, Hall JE, Handelsman D, Hankinson S, Rosner W, Singh RJ, Sluss PM, Stanczyk FZ. Endocrinology. 2014 Dec;155(12):4603. doi: 10.1210/en.2014-1735. Epub 2014 Oct 29. No abstract available.
  4. Editorial: The new instructions to authors for the reporting of steroid hormone measurements. Wierman ME, Auchus RJ, Haisenleder DJ, Hall JE, Handelsman D, Hankinson S, Rosner W, Singh RJ, Sluss PM, Stanczyk FZ. J Clin Endocrinol Metab. 2014 Dec;99(12):4375. doi: 10.1210/jc.2014-3424. No abstract available.
  5. Editorial: The new instructions to authors for the reporting of steroid hormone measurements.
    Wierman ME, Auchus RJ, Haisenleder DJ, Hall JE, Handelsman D, Hankinson S, Rosner W, Singh RJ, Sluss PM, Stanczyk FZ. Endocr Rev. 2014 Dec;35(6):849. doi: 10.1210/er.2014-1067. Epub 2014 Oct 29. No abstract available.Contact

Contact

Massachusetts General Hospital
Bulfinch 051
55 Fruit Street
Boston, MA 02114

Phone: 617-726-4352
Fax: 617-726-9330